Application 091079
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 5MG | No | No |
| 002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 20MG | No | No |
| 003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091079-001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | ||
| A091079-002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | ||
| A091079-003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091079-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | 2017-04-24 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091079-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | 2017-04-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091079-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | 2017-04-24 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A091079-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091079-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091079-003 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | A091079-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091079-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091079-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A091079-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091079-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091079-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_rx | 1ba299e7-0651-c23b-e063-6294a90a0245 | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | e64c3b3b-d5e7-6d46-e053-2a95a90a1b64 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | direct rx | b57e47a5-43e0-d1c5-e053-2a95a90a2b07 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Aurobindo Pharma Limited | 8c94d403-809b-43b9-834f-3ecd330d2dd9 | 2025-01-04 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Proficient Rx LP | eff8b514-bb7f-427e-a267-7dee25fff611 | 2024-11-01 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | c620361a-dc2d-28a1-e053-2995a90abd14 | 2024-10-29 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Rising Pharma Holdings, Inc. | b02ff20e-3f0e-43f4-a7b5-6ce56295d023 | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 16754802-d5a4-0350-e063-6394a90aa967 | 2024-09-26 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 8a021ffc-8b11-4ddf-81c4-87515971fdee | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | a4ceea38-8fff-4317-be04-8dc22222ec70 | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | afcfc1eb-29b1-46e8-a013-5cbb1737a232 | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Cadila Pharmaceuticals Limited | c5416a9f-1dcc-4851-bbc0-6664d22fc8fa | 2024-08-05 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 879630ff-662a-40bd-b74f-a864661dea95 | 2024-06-13 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 25431c8c-9f6e-42e7-ab84-4b062755bfe3 | 2024-05-29 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | QUALLENT PHARMACEUTICALS HEALTH LLC | 98f930d5-f7c2-4870-92b4-0ad37ce45797 | 2024-05-14 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 16752f60-655a-f727-e063-6394a90a96b6 | 2024-04-19 | Boxed warning, Warnings, Adverse reactions | Olmesartan Medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | fe80fd21-fa8d-474e-ac0a-23f0e1eb7f3b | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | c35408d2-a4b5-43de-8dab-f74a60fa9853 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Novadoz Pharmaceuticals LLC | 4238a064-1bfd-4ce3-b9d9-12c96eee8af0 | 2023-11-30 | Boxed warning, Warnings, Adverse reactions | Olmesartan medoxomil OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | b55b6172-d986-4fd9-ba85-a8393c908949 | 2023-11-07 | Boxed warning, Warnings, Adverse reactions | olmesartan medoxomil OLMESARTAN MEDOXOMIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-7611 | Olmesartan Medoxomil | Olmesartan Medoxomil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7612 | Olmesartan Medoxomil | Olmesartan Medoxomil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-3105 | Olmesartan Medoxomil | Olmesartan Medoxomil | A-S Medication Solutions | ANDA | Current |
| 50090-3107 | Olmesartan Medoxomil | Olmesartan Medoxomil | A-S Medication Solutions | ANDA | Current |
| 63629-7267 | Olmesartan Medoxomil | Olmesartan Medoxomil | Bryant Ranch Prepack | ANDA | Current |
| 71335-0018 | Olmesartan Medoxomil | Olmesartan Medoxomil | Bryant Ranch Prepack | ANDA | Current |